Economic burden of spinal muscular atrophy: an analysis of claims data

Background: Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disease. Objective: Characterize direct costs associated with SMA management. Data source: Truven Health Analytics MarketScan claims data (2012–2016). Patients: Eligible patients had ≥2 SMA-related medical claims ≥30 days apar...

Descripción completa

Detalles Bibliográficos
Autores principales: Belter, Lisa, Cruz, Rosángel, Kulas, Sierra, McGinnis, Emily, Dabbous, Omar, Jarecki, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655070/
https://www.ncbi.nlm.nih.gov/pubmed/33224449
http://dx.doi.org/10.1080/20016689.2020.1843277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655070/
https://www.ncbi.nlm.nih.gov/pubmed/33224449
http://dx.doi.org/10.1080/20016689.2020.1843277

Ejemplares similares